We wish to inform the changes in the SMP of the Company, arising due to completion of contractual arrangements between the company and Mr. Sendhil Pani, Managing Director of Sudeep Pharma USA Inc., (Wholly Owned Subsidiary of Sudeep Pharma Limited) w.e.f. 2nd October 2026. Kindly take the note of the same.
Exchange summary